BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 32680613)

  • 1. Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.
    Schirmer DA; Kulkarni AD; Zhang Y; Kawwass JF; Boulet SL; Kissin DM
    Fertil Steril; 2020 Sep; 114(3):567-578. PubMed ID: 32680613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh versus frozen embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome System study.
    Gerber RS; Fazzari M; Kappy M; Cohen A; Galperin S; Lieman H; Jindal S; Buyuk E
    Fertil Steril; 2020 Dec; 114(6):1225-1231. PubMed ID: 33012553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between the number of oocytes retrieved for IVF, perinatal outcome and obstetric complications.
    Magnusson Å; Wennerholm UB; Källén K; Petzold M; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2018 Oct; 33(10):1939-1947. PubMed ID: 30124838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States.
    Kawwass JF; Kulkarni AD; Hipp HS; Crawford S; Kissin DM; Jamieson DJ
    Fertil Steril; 2016 Dec; 106(7):1742-1750. PubMed ID: 27666564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The number of oocytes retrieved during IVF: a balance between efficacy and safety.
    Magnusson Å; Källen K; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2018 Jan; 33(1):58-64. PubMed ID: 29136154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
    Crawford S; Boulet SL; Kawwass JF; Jamieson DJ; Kissin DM
    Fertil Steril; 2017 Jan; 107(1):110-118. PubMed ID: 27842997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.
    Bar-Hava I; Mizrachi Y; Karfunkel-Doron D; Omer Y; Sheena L; Carmon N; Ben-David G
    Fertil Steril; 2016 Aug; 106(2):330-3. PubMed ID: 27114332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester pregnancy loss after fresh and frozen in vitro fertilization cycles.
    Hipp H; Crawford S; Kawwass JF; Chang J; Kissin DM; Jamieson DJ
    Fertil Steril; 2016 Mar; 105(3):722-728. PubMed ID: 26627121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles.
    Steward RG; Lan L; Shah AA; Yeh JS; Price TM; Goldfarb JM; Muasher SJ
    Fertil Steril; 2014 Apr; 101(4):967-73. PubMed ID: 24462057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome.
    Luke B; Brown MB; Morbeck DE; Hudson SB; Coddington CC; Stern JE
    Fertil Steril; 2010 Sep; 94(4):1399-1404. PubMed ID: 19591989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles.
    Sousa M; Cunha M; Teixeira da Silva J; Oliveira C; Silva J; Viana P; Barros A
    Reprod Biol Endocrinol; 2015 Jun; 13():66. PubMed ID: 26100393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and outcomes of gestational surrogacy in the United States.
    Perkins KM; Boulet SL; Jamieson DJ; Kissin DM;
    Fertil Steril; 2016 Aug; 106(2):435-442.e2. PubMed ID: 27087401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcomes in patients with late-onset severe OHSS following different methods of ascetic fluid drainage and a comparison with non-OHSS IVF patients.
    Ren Y; Li R; Yang S; Yang R; Song D
    Arch Gynecol Obstet; 2022 Jun; 305(6):1587-1594. PubMed ID: 35059793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpregnancy interval and singleton pregnancy outcomes after frozen embryo transfer.
    Quinn MM; Rosen MP; Allen IE; Huddleston HG; Cedars MI; Fujimoto VY
    Fertil Steril; 2019 Jun; 111(6):1145-1150. PubMed ID: 30955846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fresh versus frozen-thawed blastocyst transfer in high responders.
    Kalem Z; Namli Kalem M; Ruso H; Bakirarar B; Gurgan T
    Ginekol Pol; 2018; 89(8):407-413. PubMed ID: 30215458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous cycles for in vitro fertilization?
    Londra L; Moreau C; Strobino D; Bhasin A; Zhao Y
    Fertil Steril; 2016 Sep; 106(3):666-72. PubMed ID: 27320035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cycle IVF reduces the risk of low birthweight infants compared with conventional stimulated IVF.
    Mak W; Kondapalli LA; Celia G; Gordon J; DiMattina M; Payson M
    Hum Reprod; 2016 Apr; 31(4):789-94. PubMed ID: 26908846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe ovarian hyperstimulation syndrome modifies early maternal serum beta-human chorionic gonadotropin kinetics, but obstetrical and neonatal outcomes are not impacted.
    Choux C; Barberet J; Ginod P; Cottenet J; Bruno C; Benzénine E; Sagot P; Fauque P
    Fertil Steril; 2017 Oct; 108(4):650-658.e2. PubMed ID: 28911926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.